
GK Daily Special Edition: The Biological Missile — Inside the HER2 Antibody-Drug Conjugate Chasing Down Enhertu
Picture a cancer cell covered in a particular protein marker, like a flag planted on its surface. Now picture a drug that reads that flag, docks onto it, and only then releases its payload of chemotherapy directly inside that cell, sparing the healthy tissue around it. That is the design principle behind one of the most closely watched new cancer drugs to come out of China, and the trial data piling up behind it are strong enough to make oncologists sit up: a median of more than thirty months without the cancer progressing, in people with an advanced and previously hard-to-control form of...
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.